10 Johnson & Johnson regulatory affairs leaders
Paul Imm, Executive Director Global Regulatory Affairs at Johnson & Johnson, leads this list of Johnson & Johnson regulatory affairs leaders, whose other titles cover MedTech surgery, robotics and digital, North America, oncology and regulatory policy. A reader can learn how regulatory affairs leaders work at Johnson & Johnson from people who have held the role.
Professionals to explore
Anna Libman
LinkedInExperience: Sr. Director Regulatory Affairs Robotics & Digital · Johnson & Johnson MedTech
Anna Libman has been Sr. Director Regulatory Affairs Robotics & Digital at Johnson & Johnson MedTech since January 2025, based in the San Francisco Bay Area. Anna Libman was Director, Regulatory Affairs, Robotics & Digital Solutions at Johnson & Johnson from 2020 to 2025 and Director, Regulatory Affairs at Auris Health, Inc. from 2019 to 2020.
Cindy Abraham
LinkedInExperience: Senior Director, Global Regulatory Affairs, MedTech Surgery · Johnson & Johnson
Cindy Abraham has been Senior Director, Global Regulatory Affairs, MedTech Surgery at Johnson & Johnson since June 2026, based in Philadelphia, Pennsylvania. At Johnson & Johnson, Cindy Abraham was Director, Regulatory Affairs, Innovative Medicine, Neuroscience from 2023 to 2026, Director, Global Regulatory Affairs, MedTech Surgery from 2019 to 2023 and Director, US Regulatory Affairs, OTC Drugs & Devices from 2018 to 2019.
Elise Mazzola
LinkedInExperience: Director, North America Regulatory Leader · Johnson & Johnson
Elise Mazzola has been Director, North America Regulatory Leader at Johnson & Johnson since May 2023, based in Whitehouse Station, New Jersey. At Johnson & Johnson, Elise Mazzola was Associate Director, North America Regulatory Leader from 2019 to 2023, Manager, Regulatory Affairs from 2015 to 2019 and Senior Associate, Regulatory Affairs from 2007 to 2015.
Emily Nesbitt, RAC
LinkedInExperience: Director, Regulatory Affairs, Ethicon Software and Capital Medical Device · Johnson & Johnson
Emily Nesbitt has been Director, Regulatory Affairs, Ethicon Software and Capital Medical Device at Johnson & Johnson since January 2022, based in Cincinnati, Ohio. At Johnson & Johnson, Emily Nesbitt was Associate Director - EndoMechanical, Energy Franchises and Acquisition Integration from 2018 to 2022, and the profile headline reads RAPS RAC Board Chair.
Joe Chmielewski
LinkedInExperience: Director Regulatory Affairs · Johnson & Johnson MedTech
Joe Chmielewski has been Director Regulatory Affairs at Johnson & Johnson MedTech since April 2021, based in Pennington, New Jersey. At Johnson & Johnson MedTech, Joe Chmielewski was Associate Director Regulatory Affairs from 2017 to 2021 and Manager, Regulatory Affairs from 2011 to 2012, and the profile describes leading medical device, biologic and combination product portfolios.
Mohamed Shariff
LinkedInExperience: Director Regulatory Affairs J&J MedTech Surgery · Johnson & Johnson
Mohamed Shariff has been Director Regulatory Affairs J&J MedTech Surgery at Johnson & Johnson since June 2023, based in the New York City Metropolitan Area. Mohamed Shariff was Associate Director Regulatory Affairs, NeuWave Medical Regulatory Platform Leader at Johnson & Johnson MedTech from 2022 to 2023 and Sr. Manager Regulatory Affairs at Cepheid from 2021 to 2022.
Paul Imm
LinkedInExperience: Executive Director Global Regulatory Affairs at Johnson & Johnson · Johnson & Johnson Innovative Medicine
Paul Imm has been Executive Director Global Regulatory Affairs at Johnson & Johnson Innovative Medicine since June 2026, based in Greater Philadelphia. The listing also shows Paul Imm as Senior Director Global Regulatory Affairs at Johnson & Johnson Innovative Medicine since 2023 and Director Global Regulatory Affairs at Johnson & Johnson since 2018, and as Manager, Global Labeling at Merck from 2005 to 2010.
Raja Agnihotram
LinkedInExperience: Director, Global Regulatory Affairs, Oncology · Johnson & Johnson Innovative Medicine
Raja Agnihotram has been Director, Global Regulatory Affairs, Oncology at Johnson & Johnson Innovative Medicine since June 2022, based in the Raleigh-Durham-Chapel Hill Area. At Novartis, Raja Agnihotram was Associate Director, Global Regulatory Affairs, Novartis Gene Therapies from 2020 to 2022 and US Head Sandoz Biopharmaceuticals Regulatory Affairs, ad interim in 2020.
Richard Lee
LinkedInExperience: Director Global Regulatory Affairs · The Janssen Pharmaceutical Companies of Johnson & Johnson
Richard Lee has been Director Global Regulatory Affairs at The Janssen Pharmaceutical Companies of Johnson & Johnson since May 2024. Richard Lee was Regulatory Strategy Lead at Spark Therapeutics, Inc. from 2022 to 2024 and, at Janssen, was Associate Director, Global Regulatory Affairs Immunology from 2020 to 2022 and Manager, Global Regulatory Affairs Immunology from 2017 to 2020.
Choose the right perspective
Match the scope named in a person's title, such as global regulatory affairs, MedTech surgery or regulatory policy, to the question you need answered. Weigh how close the scope of each person's role is to the decision you face.
Questions to take into the conversation
- 01What did you focus on first when you took on your regulatory affairs role at Johnson & Johnson?
- 02What decision in your Johnson & Johnson regulatory affairs role would you make differently today, and why?
- 03What has your own work at Johnson & Johnson taught you about building a regulatory affairs team?
Reaching Johnson & Johnson regulatory affairs leaders
How can I contact one of these Johnson & Johnson regulatory affairs leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 4 companies, including Johnson & Johnson MedTech, Johnson & Johnson and Johnson & Johnson Innovative Medicine, based on profile data retrieved on October 24, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Johnson & Johnson regulatory affairs leaders?
You choose the offer, starting at $5 per person. The offer is what the person receives, and Instant Expert's fee is added on top, so a $100 offer costs you $125. The fee is 20% of what you pay. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Johnson & Johnson regulatory affairs leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. Claude and ChatGPT can do the same through the Instant Expert connector: setup is at /docs/mcp for Claude and /docs/chatgpt for ChatGPT. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal